Dianthus therapeutics highlights recent business achievements and reports q4 and fy2023 financial results

Phase 2 magic trial in generalized myasthenia gravis (gmg) initiated in q1'24 with top-line results  anticipated in 2h'25
DNTH Ratings Summary
DNTH Quant Ranking